Model for predicting EGFR mutation status in lung cancer

Model for predicting EGFR mutation status in lung cancer

Bibliographic Details
Main Authors:	Lam Nguyen Ho, Thuong Vu Le
Format:	Article
Language:	English
Published:	European Respiratory Society 2019-12-01
Series:	Breathe
Online Access:	http://breathe.ersjournals.com/content/15/4/340.full

Similar Items

EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer
by: Thang Thanh Phan, et al.
Published: (2019-01-01)

EGFR‐plasma mutations in prognosis for non‐small cell lung cancer treated with EGFR TKIs: A meta‐analysis
by: Thang Thanh Phan, et al.
Published: (2022-08-01)

Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain Metastases
by: Lie Zheng, et al.
Published: (2022-07-01)

Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer
by: Ruiyuan Yang, et al.
Published: (2022-06-01)

Prediction of EGFR Mutation Status in Non–Small Cell Lung Cancer Based on Ensemble Learning
by: Youdan Feng, et al.
Published: (2022-06-01)

EGFR Mutation Status in Uighur Lung Adenocarcinoma Patients
by: Li SHAN, et al.
Published: (2013-02-01)

Machine Learning and Feature Selection Methods for <i>EGFR</i> Mutation Status Prediction in Lung Cancer
by: Joana Morgado, et al.
Published: (2021-04-01)

An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients
by: Berardino Prencipe, et al.
Published: (2023-06-01)

Nomogram based on preoperative CT imaging predicts the EGFR mutation status in lung adenocarcinoma
by: Guojin Zhang, et al.
Published: (2021-01-01)

Predictive Role of EGFR Mutation Status on Postoperative Prognosis in Patients  with Resected Lung Adenocarcinomas
by: Hao BAI, et al.
Published: (2013-04-01)

The number of brain metastases predicts the survival of non‐small cell lung cancer patients with EGFR mutation status
by: Jun Shao, et al.
Published: (2022-09-01)

Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer
by: Nguyen Quoc Khanh Le, et al.
Published: (2021-08-01)

The Predictive Value of EGFR Status in Non-small Cell Lung Cancer Patients Treated with EGFR-TKIs
by: Jun CHEN, et al.
Published: (2010-04-01)

EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
by: Zohra Mraihi, et al.
Published: (2018-08-01)

Detection and Evaluation of EGFR Mutation Status in Serum of Patients with Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
by: Ling MA, et al.
Published: (2013-06-01)

ALK Mutation Status in EGFR-negative Non-small-cell Lung Cancer Patients in Bulgaria
by: Djambazov Slaveyko N., et al.
Published: (2018-09-01)

Dual-energy CT-based radiomics in predicting EGFR mutation status non-invasively in lung adenocarcinoma
by: Jing-Wen Ma, et al.
Published: (2024-01-01)

EGFR amplification indicated poor prognosis in EGFR‐mutated lung cancer with leptomeningeal metastases
by: Di Geng, et al.
Published: (2024-02-01)

Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer
by: Takashi Ito, et al.
Published: (2022-02-01)

Deep-Learning-Based Predictive Imaging Biomarker Model for EGFR Mutation Status in Non-Small Cell Lung Cancer from CT Imaging
by: Abhishek Mahajan, et al.
Published: (2024-03-01)

Ascertaining an appropriate diagnostic algorithm using EGFR mutation-specific antibodies to detect EGFR status in non-small-cell lung cancer.
by: Guiyang Jiang, et al.
Published: (2013-01-01)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
by: Christi M. J. Steendam, et al.
Published: (2020-10-01)

EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
by: Fang S, et al.
Published: (2014-09-01)

Smoking habit and chemo-radiotherapy and/or surgery affect the sensitivity of EGFR plasma test in non-small cell lung cancer
by: Vinh Thanh Tran, et al.
Published: (2020-08-01)

Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status.
by: Maria Planck, et al.
Published: (2013-01-01)

Correlation between Immune Microenvironment Features and EGFR Mutation Status  in Lung Adenocarcinoma
by: Hongyu ZHU, et al.
Published: (2023-03-01)

Deep learning analysis to predict EGFR mutation status in lung adenocarcinoma manifesting as pure ground-glass opacity nodules on CT
by: Hyun Jung Yoon, et al.
Published: (2022-09-01)

Advances in detection methods for EGFR gene mutation of lung cancer
by: Shuidong FENG, et al.
Published: (2008-06-01)

The treatment of patients with advanced lung cancer associated with EGFR mutation
by: L V Bolotina
Published: (2017-06-01)

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with <i>EGFR</i> Mutations
by: Kenichi Suda, et al.
Published: (2021-06-01)

Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
by: Brian J. Thomas, et al.
Published: (2023-12-01)

EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy.
by: Vanita Noronha, et al.
Published: (2013-01-01)

Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
by: Ding-Yu Rao, et al.
Published: (2023-04-01)

Performance of 18F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer
by: Min Zhang, et al.
Published: (2020-10-01)

Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs
by: Xinyang Du, et al.
Published: (2022-05-01)

Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
by: Gao X, et al.
Published: (2019-11-01)

EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
by: Jiabao Hou, et al.
Published: (2022-04-01)

EGFR Gene Mutation Statuses in Advanced Non-small Cell Lung Cancer Patients and Their Influence on Effect of Gefitinib
by: Wei ZHONG, et al.
Published: (2012-09-01)

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
by: Azhar Ali, et al.
Published: (2018-03-01)

Primary Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs): Contexts and Comparisons in EGFR-Mutated Lung Cancer
by: Keigo Kobayashi
Published: (2023-12-01)